Newer beta-lactam antibiotics

被引：3

作者：

Chandrasekar, PH

Alangaden, GJ

机构：

[1] Division of Infectious Diseases, Department of Internal Medicine, Wayne State Univ. School of Medicine, Detroit, MI

[2] Division of Infectious Diseases, Wayne State University, School of Medicine, Detroit, MI 48201

来源：

CURRENT OPINION IN INFECTIOUS DISEASES | 1996年 / 9卷 / 06期

关键词：

D O I：

10.1097/00001432-199612000-00006

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

After many years, new broad-spectrum beta-lactam drugs have become available for clinical use. Meropenem, unlike imipenem, can be administered as a single agent, is useful in the treatment of meningitis and is better tolerated, Cefepime, a fourth-generation cephalosporin, is effective against ceftazidime-resistant Gram-negative bacilli such as Pseudomonas and Enterobacter, Both drugs have advantages over existing compounds, and are expected to be used in a restricted fashion in the hospital environment.

引用

页码：391 / 397

页数：7

共 58 条

[1] IN-VITRO ACTIVITIES OF CEFOTAXIME, CEFTRIXONE, CEFTAZIDIME CEFPIROME, AND PENICILLIN AGAINST STREPTOCOCCUS-PNEUMONIAE ISOLATES [J].

BARRY, AL ;

BROWN, SD ;

NOVICK, WJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (10) :2193-2196

[2] SEQUENTIAL, SINGLE-DOSE PHARMACOKINETIC EVALUATION OF MEROPENEM IN HOSPITALIZED INFANTS AND CHILDREN [J].

BLUMER, JL ;

REED, MD ;

KEARNS, GL ;

JACOBS, RF ;

GOOCH, WM ;

YOGEV, R ;

WILLIMS, K ;

EWING, BJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (08) :1721-1725

[3]

BLUMER JL, 1995, SCAND J INFECT DIS, P38

[4]

BOOGAERTS MA, 1995, J ANTIMICROB CHEMOTH, V36, P185

[5] EFFECTIVE TREATMENT OF CEPHALOSPORIN-RIFAMPIN COMBINATIONS AGAINST CRYPTIC METHICILLIN-RESISTANT BETA-LACTAMASE-PRODUCING COAGULASE-NEGATIVE STAPHYLOCOCCAL EXPERIMENTAL ENDOCARDITIS [J].

BRANDT, CM ;

ROUSE, MS ;

TALLAN, BM ;

LAUE, NW ;

WILSON, WR ;

STECKELBERG, JM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (08) :1815-1819

[6] CLINICAL-EVALUATION OF MEROPENEM VERSUS CEFTAZIDIME FOR THE TREATMENT OF PSEUDOMONAS SPP INFECTIONS IN CYSTIC-FIBROSIS PATIENTS [J].

BYRNE, S ;

MADDISON, J ;

CONNOR, P ;

DOUGHTY, I ;

DODD, M ;

JENNEY, M ;

WEBB, AK ;

DAVID, TJ .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 36 :135-143

[7] MEROPENEM VERSUS TOBRAMYCIN PLUS CLINDAMYCIN FOR TREATMENT OF INTRAABDOMINAL INFECTIONS - RESULTS OF A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND CLINICAL-TRIAL [J].

CONDON, RE ;

WALKER, AP ;

SIRINEK, KR ;

WHITE, PW ;

FABIAN, TC ;

NICHOLS, RL ;

WILSON, SE .

CLINICAL INFECTIOUS DISEASES, 1995, 21 (03) :544-550

[8] A MULTICENTER COMPARATIVE-STUDY OF MEROPENEM AND IMIPENEM/CILASTATIN IN THE TREATMENT OF COMPLICATED URINARY-TRACT INFECTIONS IN HOSPITALIZED-PATIENTS [J].

COX, CE ;

HOLLOWAY, WJ ;

GECKLER, RW .

CLINICAL INFECTIOUS DISEASES, 1995, 21 (01) :86-92

[9] CEFEPIME [J].

CUNHA, BA ;

GILL, MV .

MEDICAL CLINICS OF NORTH AMERICA, 1995, 79 (04) :721-732

[10]

DRUSANO GL, 1995, SCAND J INFECT DIS, P11

← 1 2 3 4 5 6 →